Therefore, we hypothesize that BPC157 may reduce intracellular ROS levels through an antioxidant mechanism similar to that reported in J Clin Invest [19], thereby stabilizing BACH1 protein and enabling its pro-angiogenic function
The primary difference lies in their mechanism of action
Injections, such as Wegovy and Ozempic, are typically administered subcutaneously once a week, while oral tablets like Rybelsus can be taken daily
However, MT-2 has been studied primarily as a research compound, not as an FDA-approved obesity therapy, so long-term human data at standardized doses doesn't exist
It is effective, effortless and simple to use
Project of Administration of Traditional Chinese Medicine of Guangdong Province of China (20211403)